Literature DB >> 33679687

Insulin Reduces Inflammation by Regulating the Activation of the NLRP3 Inflammasome.

Yu-Wei Chang1,2, Ling-Chien Hung3,4, Yu-Cheng Chen3,4, Wen-Hung Wang3,4, Chun-Yu Lin1,3,4, Hsin-Han Tzeng1, Jau-Ling Suen1,5,6, Yen-Hsu Chen3,4,7,8.   

Abstract

The NOD-, LRR-, and pyrin domain-containing protein 3 (NLRP3) inflammasome is the platform for IL-1β maturation, aimed at mediating a rapid immune response against danger signals which must be tightly regulated. Insulin is well known as the critical hormone in the maintenance of glucose in physiologic response. Previous studies have proved insulin has the anti-inflammatory effect but the molecular mechanism of immunomodulation provided by insulin is not clear so far. Here we investigated whether insulin reduces inflammation by regulating the NLRP3 inflammasome. In the present study, we used LPS and ATP to induce the intracellular formation of the NLRP3 inflammasome. Insulin inhibited the secretion of IL-1β by preventing the assembly of the ASC in THP-1 cells and human CD14+ monocyte-derived macrophages. The phosphorylation status of Syk, p38 mitogen-activated protein kinase (MAPK) and ASC were altered by insulin. These effects were attenuated in THP-1 cells transfected with small interfering RNA targeting insulin receptors. In vivo, administration of glucose-insulin-potassium reduced serum IL-1β level, intestinal ASC speck formation, local macrophage infiltration and alleviated intestinal injury in mice exposed to LPS. Insulin may play an immunomodulatory role in anti-inflammation by regulating the NLRP3 inflammasome.
Copyright © 2021 Chang, Hung, Chen, Wang, Lin, Tzeng, Suen and Chen.

Entities:  

Keywords:  ASC; LRR-; and pyrin domain-containing protein 3 (NLRP3); immunomodulation; inflammasome; insulin; nucleotide binding oligomerization domain (NOD)-

Year:  2021        PMID: 33679687      PMCID: PMC7933514          DOI: 10.3389/fimmu.2020.587229

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  50 in total

Review 1.  Sensing damage by the NLRP3 inflammasome.

Authors:  Jaklien C Leemans; Suzanne L Cassel; Fayyaz S Sutterwala
Journal:  Immunol Rev       Date:  2011-09       Impact factor: 12.988

2.  Interleukin-1beta modulates proinflammatory cytokine production in human epithelial cells.

Authors:  Mehmet A Eskan; Manjunatha R Benakanakere; Beate G Rose; Ping Zhang; Jiawei Zhao; Panagiota Stathopoulou; Daisuke Fujioka; Denis F Kinane
Journal:  Infect Immun       Date:  2008-03-10       Impact factor: 3.441

Review 3.  Biologic basis for interleukin-1 in disease.

Authors:  C A Dinarello
Journal:  Blood       Date:  1996-03-15       Impact factor: 22.113

4.  Syk kinase signalling couples to the Nlrp3 inflammasome for anti-fungal host defence.

Authors:  Olaf Gross; Hendrik Poeck; Michael Bscheider; Catherine Dostert; Nicole Hannesschläger; Stefan Endres; Gunther Hartmann; Aubry Tardivel; Edina Schweighoffer; Victor Tybulewicz; Attila Mocsai; Jürg Tschopp; Jürgen Ruland
Journal:  Nature       Date:  2009-04-01       Impact factor: 49.962

5.  The adaptor ASC has extracellular and 'prionoid' activities that propagate inflammation.

Authors:  Bernardo S Franklin; Lukas Bossaller; Dominic De Nardo; Jacqueline M Ratter; Andrea Stutz; Gudrun Engels; Christoph Brenker; Mark Nordhoff; Sandra R Mirandola; Ashraf Al-Amoudi; Matthew S Mangan; Sebastian Zimmer; Brian G Monks; Martin Fricke; Reinhold E Schmidt; Terje Espevik; Bernadette Jones; Andrew G Jarnicki; Philip M Hansbro; Patricia Busto; Ann Marshak-Rothstein; Simone Hornemann; Adriano Aguzzi; Wolfgang Kastenmüller; Eicke Latz
Journal:  Nat Immunol       Date:  2014-06-22       Impact factor: 25.606

6.  Critical Role for the NLRP3 Inflammasome in Mediating IL-1β Production in Shigella sonnei-Infected Macrophages.

Authors:  Lan-Hui Li; Tzu-Ling Chen; Hsiao-Wen Chiu; Chung-Hua Hsu; Chien-Chun Wang; Tzu-Ting Tai; Tz-Chuen Ju; Fang-Hsin Chen; Oleg V Chernikov; Wen-Chiuan Tsai; Kuo-Feng Hua
Journal:  Front Immunol       Date:  2020-06-03       Impact factor: 7.561

7.  HSP70 is a negative regulator of NLRP3 inflammasome activation.

Authors:  Pierre Martine; Angélique Chevriaux; Valentin Derangère; Lionel Apetoh; Carmen Garrido; François Ghiringhelli; Cédric Rébé
Journal:  Cell Death Dis       Date:  2019-03-15       Impact factor: 8.469

8.  Endothelial cell pyroptosis plays an important role in Kawasaki disease via HMGB1/RAGE/cathespin B signaling pathway and NLRP3 inflammasome activation.

Authors:  Chang Jia; Jian Zhang; Huanwen Chen; Yingzhi Zhuge; Huiqiao Chen; Fanyu Qian; Kailiang Zhou; Chao Niu; Fangyan Wang; Huixian Qiu; Zhenquan Wang; Jian Xiao; Xing Rong; Maoping Chu
Journal:  Cell Death Dis       Date:  2019-10-14       Impact factor: 8.469

9.  USP7 and USP47 deubiquitinases regulate NLRP3 inflammasome activation.

Authors:  Pablo Palazón-Riquelme; Jonathan D Worboys; Jack Green; Ana Valera; Fatima Martín-Sánchez; Carolina Pellegrini; David Brough; Gloria López-Castejón
Journal:  EMBO Rep       Date:  2018-09-11       Impact factor: 8.807

10.  Dengue Virus Serotype 2 and Its Non-Structural Proteins 2A and 2B Activate NLRP3 Inflammasome.

Authors:  Gaurav Shrivastava; Giovani Visoso-Carvajal; Julio Garcia-Cordero; Moisés Leon-Juarez; Bibiana Chavez-Munguia; Tomas Lopez; Porfirio Nava; Nicolás Villegas-Sepulveda; Leticia Cedillo-Barron
Journal:  Front Immunol       Date:  2020-03-10       Impact factor: 7.561

View more
  9 in total

1.  Insulin infusion decreases medium-sized extracellular vesicles in adults with metabolic syndrome.

Authors:  Emily M Heiston; Anna Ballantyne; Nathan R Stewart; Sabrina La Salvia; Luca Musante; Joanne Lanningan; Uta Erdbrügger; Steven K Malin
Journal:  Am J Physiol Endocrinol Metab       Date:  2022-07-20       Impact factor: 5.900

Review 2.  Reprogramming Macrophage Metabolism and its Effect on NLRP3 Inflammasome Activation in Sepsis.

Authors:  Ruiheng Luo; Xizhe Li; Dan Wang
Journal:  Front Mol Biosci       Date:  2022-06-29

3.  Apparent Association of Insulin With Interleukin-6 (IL-6) in Severe COVID-19 Patients Having Chronic Disease Comorbidities.

Authors:  Fatimah A Nouh; Hajir Othman; Enass K Gwarsha; Agila A Elbadry; Akram Alabdali; Idris F Barassi; Salem Elamary; Abdelsalam A Elbadry; Farag A Elshaari
Journal:  Cureus       Date:  2022-04-03

Review 4.  Cross-Talk between the Cytokine IL-37 and Thyroid Hormones in Modulating Chronic Inflammation Associated with Target Organ Damage in Age-Related Metabolic and Vascular Conditions.

Authors:  Ljiljana Trtica Majnarić; Zvonimir Bosnić; Mario Štefanić; Thomas Wittlinger
Journal:  Int J Mol Sci       Date:  2022-06-09       Impact factor: 6.208

5.  Intranasal insulin modulates cerebrospinal fluid markers of neuroinflammation in mild cognitive impairment and Alzheimer's disease: a randomized trial.

Authors:  Derek Kellar; Thomas Register; Samuel N Lockhart; Paul Aisen; Rema Raman; Robert A Rissman; James Brewer; Suzanne Craft
Journal:  Sci Rep       Date:  2022-01-25       Impact factor: 4.379

6.  Using Convolutional Neural Network as a Statistical Algorithm to Explore the Therapeutic Effect of Insulin Liposomes on Corneal Inflammation.

Authors:  Yukun Liao; Huiting Jiang; Yangrui Du; Xiaojing Xiong; Yu Zhang; Zhiyu Du
Journal:  Comput Intell Neurosci       Date:  2022-07-31

Review 7.  Inflammasome NLRP3 Potentially Links Obesity-Associated Low-Grade Systemic Inflammation and Insulin Resistance with Alzheimer's Disease.

Authors:  Anna Litwiniuk; Wojciech Bik; Małgorzata Kalisz; Agnieszka Baranowska-Bik
Journal:  Int J Mol Sci       Date:  2021-05-25       Impact factor: 5.923

8.  Clustering Inflammatory Markers with Sociodemographic and Clinical Characteristics of Patients with Diabetes Type 2 Can Support Family Physicians' Clinical Reasoning by Reducing Patients' Complexity.

Authors:  Zvonimir Bosnic; Pinar Yildirim; František Babič; Ines Šahinović; Thomas Wittlinger; Ivo Martinović; Ljiljana Trtica Majnaric
Journal:  Healthcare (Basel)       Date:  2021-12-06

9.  Omarigliptin ameliorated high glucose-induced nucleotide oligomerization domain-like receptor protein 3 (NLRP3) inflammasome activation through activating adenosine monophosphate-activated protein kinase α (AMPKα) in renal glomerular endothelial cells.

Authors:  Ling Li; Kelei Qian; Yuli Sun; Yong Zhao; Yun Zhou; Ying Xue; Xinyu Hong
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.